SCHEMBL19512901

SCHEMBL19512901

COC(=O)c1ccccc1-c1cccc(Cn2ncc3ccccc32)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 4/20 0.50
SLC6A4 P31645 3/20 0.50
SLC6A2 P23975 1/20 0.50
RECQL P46063 1/20 0.49
CTSL P07711 1/20 0.43
AGTR1 P30556 1/20 0.43
AGTR2 P50052 1/20 0.43
GRM5 P41594 1/20 0.41
KAT7 O95251 1/20 0.41
KAT6A Q92794 1/20 0.41
KMO O15229 1/20 0.40
TOP2A P11388 1/20 0.40
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ABHD6 Q9BV23 1/20 0.39
ROCK2 O75116 1/20 0.39
CSF1R P07333 1/20 0.39
KDR P35968 1/20 0.39
FLT3 P36888 1/20 0.39
GSK3A P49840 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30285311 1.00 SLC6A3 (0.50) SLC6A3SLC6A4SLC6A2RECQLCTSL
SCHEMBL30284964 0.91 SLC6A3 (0.49) SLC6A3SLC6A4SLC6A2RECQLAGTR1
SCHEMBL19513142 0.91 SLC6A3 (0.49) SLC6A3SLC6A4SLC6A2RECQLAGTR1
SCHEMBL30284989 0.77 MEN1 (0.53) SLC6A3SLC6A4SLC6A2AGTR1AGTR2
SCHEMBL20914481 0.77 MEN1 (0.53) SLC6A3SLC6A4SLC6A2AGTR1AGTR2
SCHEMBL30285026 0.77 SLC6A3 (0.50) SLC6A3SLC6A4SLC6A2CTSLAGTR1
SCHEMBL19475034 0.77 SLC6A3 (0.50) SLC6A3SLC6A4SLC6A2CTSLAGTR1
SCHEMBL3724300 0.76 RECQL (0.60) RECQLKMOKMT2ARAB9A
SCHEMBL27612614 0.76 NPBWR1 (0.50) RECQLKAT7KAT6AKMOKMT2A
SCHEMBL22071077 0.75 SLC6A3 (0.58) SLC6A3SLC6A4SLC6A2CTSLGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109311813-B Palladium-catalyzed meta-C-H functionalized universal ligands 斯克利普斯研究院 2023-02-28 CN disclosed
US-10696635-B2 Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates THE SCRIPPS RESEARCH INSTITUTE (US) 2020-06-30 US disclosed
US-10696635-B2 Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates THE SCRIPPS RESEARCH INSTITUTE (US) 2020-06-30 US disclosed
US-20190119212-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS THE SCRIPPS RESEARCH INSTITUTE 2019-04-25 US disclosed
US-20190119212-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS THE SCRIPPS RESEARCH INSTITUTE 2019-04-25 US disclosed
WO-2017184589-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS THE SCRIPPS RESEARCH INSTITUTE (US) 2017-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190119212-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS AHR, PAH, DOHH SLC6A3 242/4885SLC6A4 934/4885SLC6A2 281/4885
US-10696635-B2 Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates PAH, AHR, DDC SLC6A3 434/4885SLC6A4 1147/4885SLC6A2 306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.